These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3896843)

  • 61. [Basic information and clinical application of Kanendomycin].
    Umezawa H
    Nihon Ishikai Zasshi; 1969 Sep; 62(6):514-9. PubMed ID: 5390374
    [No Abstract]   [Full Text] [Related]  

  • 62. Preclinical toxicology studies with tobramycin.
    Welles JS; Emmerson JL; Gibson WR; Nickander R; Owen NV; Anderson RC
    Toxicol Appl Pharmacol; 1973 Jul; 25(3):398-409. PubMed ID: 4728069
    [No Abstract]   [Full Text] [Related]  

  • 63. [Prevention of postvaccinal reactions].
    Gapochko KG; Savel'ev AP; Vasilenko AZh
    Voen Med Zh; 1988 Jan; (1):48-50. PubMed ID: 3259049
    [No Abstract]   [Full Text] [Related]  

  • 64. [Toxicological characteristics of hydroxyethylated diisononyl phenol].
    Sytnik IA; Tkachuk NI; Ostroverkhov VG; Kovanova En; Falendysh LR
    Gig Sanit; 1987 Jul; (7):85-6. PubMed ID: 3666510
    [No Abstract]   [Full Text] [Related]  

  • 65. Effects of chemicals on health--3. Toxicological testing.
    Nutt AR
    Occup Health (Lond); 1985 Jan; 37(1):18-27. PubMed ID: 3845414
    [No Abstract]   [Full Text] [Related]  

  • 66. [Local tolerance of nourseothricin].
    Chemnitius KH; Grass M; Schönberg I
    Arch Exp Veterinarmed; 1986 Sep; 40(5):736-43. PubMed ID: 3028307
    [No Abstract]   [Full Text] [Related]  

  • 67. Safety evaluations of a synthetic antimicrobial peptide administered intravenously in rats and dogs.
    Cresti L; Falciani C; Cappello G; Brunetti J; Vailati S; Melloni E; Bracci L; Pini A
    Sci Rep; 2022 Nov; 12(1):19294. PubMed ID: 36369523
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Prospects for using antibiotics with sulfanilamides].
    Sakanian SSh
    Veterinariia; 1979 May; (5):62-4. PubMed ID: 452399
    [No Abstract]   [Full Text] [Related]  

  • 69. [Toxicological characteristics of a new nitrification inhibitor, N-[6-chlorohexyl]-carbamoyl-3(5)-methylpyrazole].
    Pogosian SB; Nazaretian KL; Buniatian IuA; Aĭvazian LK
    Gig Sanit; 1987 Jul; (7):78-9. PubMed ID: 3666506
    [No Abstract]   [Full Text] [Related]  

  • 70. Pre-clinical safety evaluation of ceftazidime.
    Capel-Edwards K; Losty CR; Tucker ML; Pratt DA
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():237-9. PubMed ID: 19802992
    [No Abstract]   [Full Text] [Related]  

  • 71. Local chemotherapy of wounds; tissue toxicity of certain antibacterial substances.
    HOWES EL
    Surg Gynecol Obstet; 1946 Jul; 83():1-14. PubMed ID: 20988033
    [No Abstract]   [Full Text] [Related]  

  • 72. [Carcinogenic activity of dioxidine].
    Shashkina LF; Ivanova VM; Lavrik OI; Proĭnova VA; Nechushkina LV
    Farmakol Toksikol; 1985; 48(1):77-80. PubMed ID: 3979542
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Preclinical investigation and standardization of metronidazole soft dosage forms].
    Abramovich RA; Koshelev IuA; Vaganova OA; Elagina IA
    Antibiot Khimioter; 2005; 50(8-9):27-31. PubMed ID: 17016908
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Case history of a biotechnology product: toxicological protocol, design and results.
    Stoll RE; Ball DJ; Burchiel SW; Robison RL; Smith CL
    Prog Clin Biol Res; 1987; 235():173-82. PubMed ID: 3496611
    [No Abstract]   [Full Text] [Related]  

  • 75. CATIONIC PROTEINS AND ANTIBACTERIAL PROPERTIES OF INFECTED TISSUES AND LEUKOCYTES.
    SPITZNAGEL JK; CHI HY
    Am J Pathol; 1963 Oct; 43(4):697-711. PubMed ID: 14068392
    [No Abstract]   [Full Text] [Related]  

  • 76. [Use of electronic computers for evaluating the morphological criteria of the therapeutic efficacy of antirheumatic agents].
    Ptashekas RS; Orlovskaia GV; Bundonis AIu; Urmonas VD
    Vopr Revm; 1977; (3):20-4. PubMed ID: 303014
    [No Abstract]   [Full Text] [Related]  

  • 77. [Use of mathematical theory in experiments evaluating the protective properties of antimicrobial preparations].
    D'iakov SI; Churnosov EV; Pervomaĭskiĭ AG; Sidorenko SV
    Antibiot Med Biotekhnol; 1986 Sep; 31(9):648-55. PubMed ID: 3777891
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The toxicity of capreomycin in laboratory animals.
    Welles JS; Harris PN; Small RM; Worth HM; Anderson RC
    Ann N Y Acad Sci; 1966 Apr; 135(2):960-73. PubMed ID: 5220249
    [No Abstract]   [Full Text] [Related]  

  • 79. [Characteristics of using Infusoria culture in toxicological studies].
    Lakhonina GM; Irlina IS; Etlin SN
    Gig Sanit; 1991 Mar; (3):81-2. PubMed ID: 1885027
    [No Abstract]   [Full Text] [Related]  

  • 80. Preclinical evaluation of novel antibacterial agents by microbiological and molecular techniques.
    O'Neill AJ; Chopra I
    Expert Opin Investig Drugs; 2004 Aug; 13(8):1045-63. PubMed ID: 15268641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.